Biotech Execs Seek Ch. 15 Pause Pending Trustee Removal

Executives with BIA Separations, the U.S. subsidiary of an Austrian biotechnology company, have asked a Delaware bankruptcy judge to delay granting the foreign company Chapter 15 recognition until efforts to remove...

Already a subscriber? Click here to view full article